Wei Shenhai, Tian Jintao, Song Xiaoping, Wu Bingqun, Liu Limin
Department of Thoracic Surgery, First Hospital of Tsinghua University, No. 6, the First Road, Jiuxianqiao, Chaoyang District, Beijing, 100016, People's Republic of China.
Department of Physiology, Capital Medical University, Beijing, 100069, People's Republic of China.
J Cancer Res Clin Oncol. 2018 Jan;144(1):145-155. doi: 10.1007/s00432-017-2522-3. Epub 2017 Oct 4.
To investigate the probability of death (POD) from any causes by time after diagnosis of non-small cell lung cancer (NSCLC) and the factors associated with survival for NSCLC patients.
A total of 202,914 patients with NSCLC from 2004 to 2013 were identified from the Surveillance, Epidemiology, and End Results (SEER) database. The overall survival (OS) and lung cancer-specific survival (LCSS) were calculated and POD from any causes at different time periods after diagnosis was explored. The predictive factors for OS, LCSS and survival from non-lung cancer deaths were investigated using multivariate analysis with Cox proportional hazards regression and competing risk regression analysis.
The 5- and 10-year OS were 20.4% and 11.5%, accordingly that for LCSS were 25.5% and 18.4%, respectively. Lung cancer contributed 88.3% (n = 128,402) of the deaths. The POD from lung cancer decreased with time after diagnosis. In multivariate analysis, advanced age and advanced stage of NSCLC were associated with decreased OS and LCSS. Comparing to no surgery, any kind of resection conferred lower risk of death from lung cancer and higher risk of dying from non-lung cancer conditions except lobectomy or bilobectomy, which was associated with lower risk of death from both lung cancer and non-lung cancer conditions.
Most of the patients with NSCLC died from lung cancer. Rational surveillance and treatment policies should be made for them. Early stage and lobectomy or bilobectomy were associated with improved OS and LCSS. It is reasonable to focus on early detection and optimal surgical treatment for NSCLC.
探讨非小细胞肺癌(NSCLC)确诊后不同时间的全因死亡概率(POD)以及NSCLC患者生存的相关因素。
从监测、流行病学和最终结果(SEER)数据库中识别出2004年至2013年共202,914例NSCLC患者。计算总生存期(OS)和肺癌特异性生存期(LCSS),并探讨确诊后不同时间段的全因POD。使用Cox比例风险回归和竞争风险回归分析的多变量分析来研究OS、LCSS和非肺癌死亡生存的预测因素。
5年和10年OS分别为20.4%和11.5%,相应地,LCSS分别为25.5%和18.4%。肺癌导致88.3%(n = 128,402)的死亡。肺癌的POD随确诊后的时间而降低。在多变量分析中,NSCLC的高龄和晚期与OS和LCSS降低相关。与未手术相比,任何一种切除术都使肺癌死亡风险降低,而非肺癌情况死亡风险升高,但肺叶切除术或双肺叶切除术除外,这两种手术与肺癌和非肺癌情况的死亡风险均降低相关。
大多数NSCLC患者死于肺癌。应为他们制定合理的监测和治疗策略。早期阶段以及肺叶切除术或双肺叶切除术与OS和LCSS改善相关。对NSCLC关注早期检测和最佳手术治疗是合理的。